Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home 2021
Archives
Proving the effectiveness of digital health technologies
Professor Freimut Schliess, Director of Science & Innovation, at the Profil Institut für Stoffwechselforschung GmbH, illustrates how dissipating initial scepticism of digital health technologies makes for a thrilling challenge for regulators, manufacturers and clinical researchers alike.
What does the European Medical Devices Regulation 2017/745 (MDR) say about clinical trials?
Professor Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH, explores how the MDR will impact clinical trials.
On the fast-track to reimbursement: Germany unlocks business opportunities for digital health innovators
Prof. Dr. Freimut Schliess discusses digital health innovation in Germany, tackling larger public health challenges being faced.
Bridging the gap between clinical trials and clinical care
Here, Tatiana Affini Dicenzo and Freimut Schliess discuss bridging the gap between clinical trials and clinical care, specifically exploring if wearables are fit for this purpose.
Continuous real-world monitoring of cardiorespiratory health
The importance of continuous real-world monitoring of cardiorespiratory health, including adding value to pivotal clinical trials.
Digital twins – are they game-changers in clinical research and clinical care?
Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH, explores if digital twins are game-changers in clinical research and clinical care.
A vision on remote decentralised clinical trials
Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH, shares a vision for remote decentralised clinical trials.
Think Tank highlights CROs key role in optimising innovation pathways
Prof Dr Freimut Schliess, Director of Profil GmbH, discusses how CROs can play a key role for the optimisation of innovation pathways.
RealWorld4Clinic – Real-life data for clinical research & care
RealWorld4Clinic is a new European initiative bringing real-world data to pivotal clinical research and outpatient cardiology care.
Trustworthy artificial intelligence in healthcare: It’s time to deliver
When it comes to trustworthy artificial intelligence (AI) in healthcare, Prof Dr Freimut Schliess from Profil GmbH, argues that now is the time to deliver.
iPDM Goes Europe: The impact on diabetes and patient care
Here, the tangible impact on diabetes patients and their care is thoroughly explored via integrated personalised diabetes management (iPDM).
Clinical Contract Research: Building the digital bridge between clinical research and clinical care
Prof Dr Freimut Schliess, Director, Science & Innovation at Profil GmbH, sheds light on how Clinical Contract Research Organisations are building the digital bridge connecting clinical research and clinical care.
A life- and disease course approach to health protection and chronic care
Taking advantage of data and trustworthy collaboration is the way to go when it comes to a life- and disease course approach to health protection and chronic care, argues Prof Dr Freimut Schliess, Director of Science & Innovation at Profil GmbH.
Artificial pancreas systems in Type 2 diabetes
Prof Dr Freimut Schliess, explores how artificial pancreas systems are revolutionising healthcare for Type 2 diabetes patients.
Digital innovation in diabetes: From health promotion to integrated care provision
Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH shares his views on data-based solutions for diabetes.
